Purchase Order HHSN272201600563P
Award Date 4/18/16
Potential Completion Date 8/16/16
Potential Value $8.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Gardner, MA 01440, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Vivitide LLC (doing business as New England Peptide) for the provision of biomaterials. The contract has a ceiling value of $12,500.00 and was awarded on August 21, 2015 with a completion date of September 20, 2015. The contract is not designated as a set-aside. Vivitide LLC is a for-profit limited liability company that...
- The National Institutes of Health (NIH) awarded a firm fixed price contract to Vivitide LLC, a manufacturer of laboratory supplies, custom peptide synthesis, monoclonal antibodies, and modified peptides. The $7,000 contract is a call order under a Blanket Purchase Agreement (BPA) to provide reagents and supplies related to the "TAS NEP ARRAY TIER 2" program. The contract was awarded on a competitive basis without a small business set-aside and has a completion date of June 11, 2010....
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID) to Vivitide LLC, a for-profit limited liability company that manufactures laboratory supplies and provides custom peptide synthesis, monoclonal antibodies, and modified peptides to the federal government. The contract has a ceiling value of $17,000.00 and is a Firm Fixed Price BPA Call. It was awarded on October 25, 2010 with a period of performance through November 30, 2010. The contract...
- The U.S. government awarded a $5,770 firm fixed price purchase order to Vivitide LLC (doing business as New England Peptide) on May 31, 2016, for the delivery of 3X affinity purified antibody packages including Oncorhyncin II, Beta Defensin, and Hepcidin, with dry ice included for shipment. The contract was completed on June 2, 2016, and performance took place in Gardner, Massachusetts. This was a civilian acquisition with no small business set-aside designation. Vivitide LLC is a specialized...
- Vivitide LLC, operating under the business name New England Peptide, was awarded a firm fixed price purchase order valued at $5,650 by a civilian federal agency with a Pacific West Area designation on January 26, 2015. The contract calls for delivery of three affinity purified antibody packages, with an ultimate completion date of April 23, 2015. The place of performance is located in Pullman, Washington. This contract was awarded without set-aside provisions. Vivitide LLC specializes in the...
- Vivitide LLC, doing business as New England Peptide, received a firm fixed-price BPA (Blanket Purchase Agreement) call award from the National Cancer Institute valued at $3,825 on July 12, 2016, with a completion date of July 30, 2016. The contract was performed in Gardner, Massachusetts, and no set-aside designation was utilized. This award represents a task order or purchase call against an existing blanket purchase agreement vehicle, reflecting the National Cancer Institute's continued...
- This is a firm-fixed-price purchase order awarded to Vivitide LLC, doing business as New England Peptide, by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services. The $26,440.00 award is for the procurement of 2x NEP Monoclonal Antibody Packages. This purchase order was issued without a set-aside and has a completion date of March 21, 2021. The original solicitation was a special notice indicating NICHD's...
- The National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, awarded a firm fixed-price purchase order contract to Peptide 2.0 Inc., doing business as Peptide 20 Inc., for the provision of custom HIV peptides. The contract has a ceiling value of $12,801.20 and an ultimate completion date of September 1, 2017. Peptide 2.0 Inc. is a minority-owned, for-profit business that specializes in custom peptide synthesis and...
- This federal contract award, identified as HHSN272201500430P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services, to the prime contractor Atlantic Peptides LLC. The contract is for the purchase of a set of 30 peptides, each at 1 milligram and 75% purity, for a fixed price of $3,900.00. The contract has a completion date of April 3, 2015 and was awarded on March 4, 2015. No set-aside designation is...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Peptide 2.0 Inc., doing business as Peptide 20 Inc., a minority-owned for-profit organization, to provide HIV-1 peptides. The potential value of this contract is $12,801.20 and the period of performance ends on June 11, 2018. This award was not set aside for small businesses. Peptide 2.0 Inc. specializes in custom...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Vivitide LLC, a manufacturer of laboratory supplies and peptides. The $8,250.00 contract is for the delivery of 96 crude peptides per plate in a 96-well single tube format. The award was not set aside for any specific business category. Vivitide LLC, also doing business as New England Pepdite, has previously received other federal contract awards from NIAID and other agencies within the Department of Health and Human Services to support drug discovery and clinical development activities in the life sciences industry.
Generated 11/24/24, 9:33 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 4/18/16 |